TrialBritish journal of clinical pharmacology2021

Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.

Ekaterina Gibiansky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.